About GLP-2 (GLP-2)
GLP-2 is the research designation for GLP-2, a dual receptor agonist that targets both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors simultaneously. By engaging two distinct incretin pathways, it represents a mechanistic evolution from single-receptor GLP-1 agonists.
GIP receptor activation influences insulin secretion in a glucose-dependent manner and may modulate adipose tissue function and energy balance. GLP-1 receptor activation reduces gastric emptying, suppresses glucagon secretion, and decreases appetite signaling through central and peripheral mechanisms. The dual agonism creates complementary and potentially synergistic effects that have made GLP-2 a subject of significant research interest in metabolic science.
Research Applications
GLP-2 (GLP-2) is used in research investigating dual incretin receptor pathway modulation, insulin sensitivity, appetite regulation, and body composition. Research applications include comparative studies between mono- and dual-receptor agonists, investigations of GIP vs. GLP-1 contribution to metabolic outcomes, and studies of gastric motility under dual-receptor conditions.